Xu, Wenshuai
Xu, Zhiyan
Liu, Yaping
Zhan, Yongzhong
Sui, Xin
Feng, Ruie
Peng, Min
Li, Xue
Wang, Jun
Meng, Shuzhen
Wang, Li
Tian, Xinlun http://orcid.org/0000-0003-4307-6665
Zhang, Xue
Xu, Kai-Feng
Funding for this research was provided by:
The National Key Research and Development Program of China (2016YFC0901502)
CAMS Innovation Fund for Medical Sciences (CIFMS 2018-I2M-1-003, CIFMS 2017-12M-2-001)
The Capital of the Public Health Program: Study on the Evaluation of Diagnosis and Treatment on Seven Treatable Rare Diseases (Z151100003915126)
Article History
Received: 22 December 2019
Accepted: 23 June 2020
First Online: 6 July 2020
Ethics approval and consent to participate
: The study was part of LAM registry study of Peking Union Medical College Hospital. The protocol of this study was approved by the Ethical Committee of Peking Union Medical College Hospital (IRB No.: S-K1209). All subjects included in this study signed informed consent documents.
: Consent for publication was obtained from all participants.
: No competing interests were declared.